2026-10-27T17:13:15Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/277522026-10-08T00:18:18Zcom_20.500.12105_19586com_20.500.12105_2202col_20.500.12105_19587

00925njm 22002777a 4500 dc Medina-Hernández, Danielle author Galán-Arriola, Carlos author Cepas, Pedro Luis author Pérez-Camargo, Daniel author Cádiz, Laura author Pereda, Daniel author Sánchez-González, Javier author García-Alvarez, Ana author Ibáñez, Borja author 2026-06-18 J Cardiovasc Transl Res. 2026 Jun 18;19(1):72. https://hdl.handle.net/20.500.12105/27752 42315808 10.1007/s12265-026-10780-w 1937-5395 Journal of cardiovascular translational research Hibernating myocardium Ischemic heart disease Large-animal model SGLT2 inhibitors Low-dose Empagliflozin Does Not Modify Myocardial Energetics and Function in a Large-animal Model of Hibernating Myocardium.